Predictive Value of Osteopontin for Contrast Nephropathy

NCT05547581 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2022-09-21

No results posted yet for this study

Summary

Early detection of contrast induced nephropathy by using osteopontin as an early marker for prediction

Conditions

  • Contrast-induced Nephropathy

Sponsors & Collaborators

  • Noura gamal

    lead OTHER

Principal Investigators

  • Mohamed Sobh · Assiut University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-07
Primary Completion
2024-11-05
Completion
2024-12-08

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05547581 on ClinicalTrials.gov